Prevest Denpro Ltd vs Transgene Biotek Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Prevest Denpro Ltd is ₹ 377.55 as of 23 Oct 15:30 . The P/E Ratio of Prevest Denpro Ltd changed from 26.3 on March 2024 to 20 on March 2026 . This represents a CAGR of -8.72% over 3 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Prevest Denpro Ltd changed from ₹ 423.77 crore on March 2024 to ₹ 410.26 crore on March 2026 . This represents a CAGR of -1.07% over 3 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Prevest Denpro Ltd for the Jun '26 is ₹ 20.38 crore as compare to the Mar '26 revenue of ₹ 20.35 crore. This represent the growth of 0.15% The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The ebitda of Prevest Denpro Ltd for the Jun '26 is ₹ 8.08 crore as compare to the Mar '26 ebitda of ₹ 8.32 crore. This represent the decline of -2.88% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The net profit of Prevest Denpro Ltd changed from ₹ 3.67 crore to ₹ 5.64 crore over 9 quarters. This represents a CAGR of 21.04% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Prevest Denpro Ltd changed from 7.64 % on March 2023 to 5.6 % on March 2026 . This represents a CAGR of -7.47% over 4 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Prevest Denpro Ltd

Prevest Denpro Limited is one of the world's leading dental materials manufacturer, which was incorporated on May 05, 1999, with the Registrar of Companies, Jammu & Kashmir.
The Company is primarily involved in the manufacturing of Dental Preparations. The Company develop, manufacture and market a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile.
The product offerings addresses majority of dentists' clinical needs for consumable dental materials.
The product portfolio covers a wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables.
The products are sold in over 75 countries in the regions of Europe, Asia, South America, Middle East and Africa.

About Transgene Biotek Ltd

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

FAQs for the comparison of Prevest Denpro Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, Prevest Denpro Ltd or Transgene Biotek Ltd?

Market cap of Prevest Denpro Ltd is 453 Cr while Market cap of Transgene Biotek Ltd is 19 Cr

What are the key factors driving the stock performance of Prevest Denpro Ltd and Transgene Biotek Ltd?

The stock performance of Prevest Denpro Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Prevest Denpro Ltd and Transgene Biotek Ltd?

As of October 24, 2026, the Prevest Denpro Ltd stock price is INR ₹377.55. On the other hand, Transgene Biotek Ltd stock price is INR ₹2.57.

How do dividend payouts of Prevest Denpro Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of Prevest Denpro Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.